Bank of New York Mellon Corp Increases Holdings in Bruker Co. (NASDAQ:BRKR)

Bank of New York Mellon Corp boosted its position in Bruker Co. (NASDAQ:BRKR - Free Report) by 7.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 988,863 shares of the medical research company's stock after buying an additional 69,806 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.65% of Bruker worth $57,967,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the company. South Dakota Investment Council purchased a new position in shares of Bruker in the fourth quarter valued at $703,000. Ieq Capital LLC grew its position in shares of Bruker by 961.0% in the fourth quarter. Ieq Capital LLC now owns 58,950 shares of the medical research company's stock valued at $3,456,000 after purchasing an additional 53,394 shares in the last quarter. Alberta Investment Management Corp purchased a new position in shares of Bruker in the fourth quarter valued at $598,000. Global Retirement Partners LLC grew its position in shares of Bruker by 16.5% in the fourth quarter. Global Retirement Partners LLC now owns 5,135 shares of the medical research company's stock valued at $301,000 after purchasing an additional 726 shares in the last quarter. Finally, New York State Common Retirement Fund boosted its stake in Bruker by 11.2% during the fourth quarter. New York State Common Retirement Fund now owns 247,355 shares of the medical research company's stock valued at $14,500,000 after buying an additional 24,916 shares during the period. 79.52% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Stifel Nicolaus dropped their price objective on Bruker from $70.00 to $57.00 and set a "hold" rating for the company in a research note on Friday, February 14th. The Goldman Sachs Group raised Bruker from a "sell" rating to a "neutral" rating and set a $60.00 price objective for the company in a research note on Thursday, December 5th. Guggenheim reissued a "buy" rating on shares of Bruker in a research note on Monday, February 24th. Barclays dropped their price objective on Bruker from $69.00 to $65.00 and set an "overweight" rating for the company in a research note on Monday, February 10th. Finally, UBS Group assumed coverage on Bruker in a research note on Tuesday, December 10th. They set a "neutral" rating and a $66.00 price objective for the company. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Bruker has an average rating of "Moderate Buy" and a consensus target price of $70.50.

Bruker Price Performance

BRKR stock traded up $0.21 during mid-day trading on Friday, hitting $48.41. 2,818,325 shares of the stock were exchanged, compared to its average volume of 1,251,696. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 0.77. The business has a fifty day moving average price of $55.17 and a 200 day moving average price of $59.20. Bruker Co. has a 12 month low of $45.29 and a 12 month high of $94.86. The stock has a market capitalization of $7.34 billion, a price-to-earnings ratio of 63.70, a PEG ratio of 2.16 and a beta of 1.16.

Bruker (NASDAQ:BRKR - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, topping the consensus estimate of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. On average, sell-side analysts anticipate that Bruker Co. will post 2.69 EPS for the current year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Stockholders of record on Monday, March 17th will be issued a $0.05 dividend. The ex-dividend date is Monday, March 17th. This represents a $0.20 annualized dividend and a dividend yield of 0.41%. Bruker's dividend payout ratio is currently 26.32%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.